Literature DB >> 33414220

Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction.

Scott B Biering1, David L Akey2, Marcus P Wong1,3, W Clay Brown2, Nicholas T N Lo1,3, Henry Puerta-Guardo1, Francielle Tramontini Gomes de Sousa1, Chunling Wang1, Jamie R Konwerski2, Diego A Espinosa1, Nicholas J Bockhaus2,4, Dustin R Glasner1, Jeffrey Li1, Sophie F Blanc1, Evan Y Juan1, Stephen J Elledge5, Michael J Mina6, P Robert Beatty1, Janet L Smith7,4, Eva Harris8.   

Abstract

Medically important flaviviruses cause diverse disease pathologies and collectively are responsible for a major global disease burden. A contributing factor to pathogenesis is secreted flavivirus nonstructural protein 1 (NS1). Despite demonstrated protection by NS1-specific antibodies against lethal flavivirus challenge, the structural and mechanistic basis remains unknown. Here, we present three crystal structures of full-length dengue virus NS1 complexed with a flavivirus-cross-reactive, NS1-specific monoclonal antibody, 2B7, at resolutions between 2.89 and 3.96 angstroms. These structures reveal a protective mechanism by which two domains of NS1 are antagonized simultaneously. The NS1 wing domain mediates cell binding, whereas the β-ladder triggers downstream events, both of which are required for dengue, Zika, and West Nile virus NS1-mediated endothelial dysfunction. These observations provide a mechanistic explanation for 2B7 protection against NS1-induced pathology and demonstrate the potential of one antibody to treat infections by multiple flaviviruses.
Copyright © 2021, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33414220      PMCID: PMC8000976          DOI: 10.1126/science.abc0476

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  43 in total

Review 1.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

2.  Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome.

Authors:  George J Xu; Tomasz Kula; Qikai Xu; Mamie Z Li; Suzanne D Vernon; Thumbi Ndung'u; Kiat Ruxrungtham; Jorge Sanchez; Christian Brander; Raymond T Chung; Kevin C O'Connor; Bruce Walker; H Benjamin Larman; Stephen J Elledge
Journal:  Science       Date:  2015-06-05       Impact factor: 47.728

3.  Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity.

Authors:  Naphak Modhiran; Daniel Watterson; David A Muller; Adele K Panetta; David P Sester; Lidong Liu; David A Hume; Katryn J Stacey; Paul R Young
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

4.  Dengue virus or NS1 protein induces trans-endothelial cell permeability associated with VE-Cadherin and RhoA phosphorylation in HMEC-1 cells preventable by Angiopoietin-1.

Authors:  Sneha Singh; M G Anupriya; Ayan Modak; Easwaran Sreekumar
Journal:  J Gen Virol       Date:  2018-10-24       Impact factor: 3.891

5.  Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.

Authors:  Magelda Montoya; Matthew Collins; Wanwisa Dejnirattisai; Leah C Katzelnick; Henry Puerta-Guardo; Ramesh Jadi; Samuel Schildhauer; Piyada Supasa; Sirijitt Vasanawathana; Prida Malasit; Juthathip Mongkolsapaya; Aruna D de Silva; Hasitha Tissera; Angel Balmaseda; Gavin Screaton; Aravinda M de Silva; Eva Harris
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

6.  Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens.

Authors:  Michael J Mina; Tomasz Kula; Yumei Leng; Mamie Li; Rory D de Vries; Mikael Knip; Heli Siljander; Marian Rewers; David F Choy; Mark S Wilson; H Benjamin Larman; Ashley N Nelson; Diane E Griffin; Rik L de Swart; Stephen J Elledge
Journal:  Science       Date:  2019-11-01       Impact factor: 47.728

7.  ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules.

Authors:  Haim Ashkenazy; Shiran Abadi; Eric Martz; Ofer Chay; Itay Mayrose; Tal Pupko; Nir Ben-Tal
Journal:  Nucleic Acids Res       Date:  2016-05-10       Impact factor: 16.971

8.  Endocytosis of flavivirus NS1 is required for NS1-mediated endothelial hyperpermeability and is abolished by a single N-glycosylation site mutation.

Authors:  Chunling Wang; Henry Puerta-Guardo; Scott B Biering; Dustin R Glasner; Edwina B Tran; Mark Patana; Trent A Gomberg; Carmel Malvar; Nicholas T N Lo; Diego A Espinosa; Eva Harris
Journal:  PLoS Pathog       Date:  2019-07-29       Impact factor: 6.823

9.  Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism.

Authors:  Henry Puerta-Guardo; Dustin R Glasner; Diego A Espinosa; Scott B Biering; Mark Patana; Kalani Ratnasiri; Chunling Wang; P Robert Beatty; Eva Harris
Journal:  Cell Rep       Date:  2019-02-05       Impact factor: 9.423

10.  Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins.

Authors:  Pietro Scaturro; Mirko Cortese; Laurent Chatel-Chaix; Wolfgang Fischl; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

View more
  22 in total

1.  Molecular Determinants of Tissue Specificity of Flavivirus Nonstructural Protein 1 Interaction with Endothelial Cells.

Authors:  Nicholas T N Lo; Susan Z Roodsari; Nicole L Tin; Marcus P Wong; Scott B Biering; Eva Harris
Journal:  J Virol       Date:  2022-09-15       Impact factor: 6.549

2.  The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.

Authors:  Gerson I Caraballo; Romel Rosales; Mercedes Viettri; Juan Manuel Castillo; Raymundo Cruz; Siyuan Ding; Harry B Greenberg; Juan E Ludert
Journal:  J Virol       Date:  2022-06-02       Impact factor: 6.549

3.  Intrinsic antiviral immunity of barrier cells revealed by an iPSC-derived blood-brain barrier cellular model.

Authors:  Yichen Cheng; Angelica Medina; Zhenlan Yao; Mausumi Basu; Janhavi P Natekar; Jianshe Lang; Egan Sanchez; Mezindia B Nkembo; Chongchong Xu; Xuyu Qian; Phuong T T Nguyen; Zhexing Wen; Hongjun Song; Guo-Li Ming; Mukesh Kumar; Margo A Brinton; Melody M H Li; Hengli Tang
Journal:  Cell Rep       Date:  2022-05-31       Impact factor: 9.995

4.  Flavivirus NS1 Triggers Tissue-Specific Disassembly of Intercellular Junctions Leading to Barrier Dysfunction and Vascular Leak in a GSK-3β-Dependent Manner.

Authors:  Henry Puerta-Guardo; Scott B Biering; Francielle Tramontini Gomes de Sousa; Jeffrey Shu; Dustin R Glasner; Jeffrey Li; Sophie F Blanc; P Robert Beatty; Eva Harris
Journal:  Pathogens       Date:  2022-05-24

5.  A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.

Authors:  Xianmiao Ye; Xinglong Liu; Ling Chen; Feng Li; Liqiang Feng; Tao Shu; Weiqi Deng; Min Liao; Yali Zheng; Xuehua Zheng; Xiaoyan Zhang; Ting Li; Wenxia Fan; Linbing Qu
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

6.  Therapeutic efficacy of humanized monoclonal antibodies targeting dengue virus nonstructural protein 1 in the mouse model.

Authors:  Sen-Mao Tien; Po-Chun Chang; Yen-Chung Lai; Yung-Chun Chuang; Chin-Kai Tseng; Yu-San Kao; Hong-Jyun Huang; Yu-Peng Hsiao; Yi-Ling Liu; Hsing-Han Lin; Chien-Chou Chu; Miao-Huei Cheng; Tzong-Shiann Ho; Chih-Peng Chang; Shu-Fen Ko; Che-Piao Shen; Robert Anderson; Yee-Shin Lin; Shu-Wen Wan; Trai-Ming Yeh
Journal:  PLoS Pathog       Date:  2022-04-29       Impact factor: 6.823

Review 7.  Molecular Insights into the Flavivirus Replication Complex.

Authors:  Kaïn van den Elsen; Jun Ping Quek; Dahai Luo
Journal:  Viruses       Date:  2021-05-21       Impact factor: 5.048

Review 8.  Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.

Authors:  Shamus P Keeler; Julie M Fox
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

Review 9.  Flavivirus NS1 and Its Potential in Vaccine Development.

Authors:  Kassandra L Carpio; Alan D T Barrett
Journal:  Vaccines (Basel)       Date:  2021-06-09

10.  Levels of Circulating NS1 Impact West Nile Virus Spread to the Brain.

Authors:  Alex W Wessel; Kimberly A Dowd; Scott B Biering; Ping Zhang; Melissa A Edeling; Christopher A Nelson; Kristen E Funk; Christina R DeMaso; Robyn S Klein; Janet L Smith; Thu Minh Cao; Richard J Kuhn; Daved H Fremont; Eva Harris; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2021-08-04       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.